Naxions

Naxions (诺信创联) is a Beijing-based pharmaceutical digital marketing company founded in 2015, providing data-driven marketing solutions to drugmakers. Per a 2018 FreeS Fund deal announcement, the company applies "data collection + analysis/management tools/business consulting + execution" to help pharmaceutical companies shift from traditional rep-based marketing to more compliant and efficient digital systems, with a particular focus on reaching grassroots and segmented markets that conventional methods struggle to penetrate . Founder and CEO Ruan Wei has described Naxions' approach as a "2.0 version" digital solution that uses big data and AI to restore fragmented data into real individual insights, improving precision and operational efficiency while protecting data security and privacy .

The company was a FreeS Fund angel investment in early 2016, with the firm continuing to follow on in subsequent rounds . In July 2018, Naxions raised a tens-of-millions RMB A+ round from IQVIA—marking the global healthcare data giant's first investment in China over its 20-plus years in the market—with proceeds directed toward talent recruitment, product R&D, and market expansion . FreeS Fund later cited Naxions as a case study in network-effect SaaS models and a beneficiary of China's healthcare reform .